Showing results (21-30 of 93) with videos related to

Sort By:
Pageof 10
The Journal of Biological Chemistry|November 3, 2012
Structural characterization of human cytochrome P450 2C19: active site differences between P450s 2C8, 2C9, and 2C19R Leila Reynald, Stefaan Sansen, C David Stout, et al.
Biochemistry|May 22, 2012
Mobility of Xe atoms within the oxygen diffusion channel of cytochrome ba(3) oxidaseV Mitch Luna, James A Fee, Ashok A Deniz, et al.
Journal of the American Chemical Society|November 26, 2004
Heterocyclic peptide backbone modifications in an alpha-helical coiled coilW Seth Horne, Maneesh K Yadav, C David Stout, et al.
ACS Chemical Biology|April 4, 2017
Halogen-π Interactions in the Cytochrome P450 Active Site: Structural Insights into Human CYP2B6 Substrate SelectivityManish B Shah, Jingbao Liu, Qinghai Zhang, et al.
Biochemistry|April 29, 2009
Crystal structures of cytochrome P450 2B4 in complex with the inhibitor 1-biphenyl-4-methyl-1H-imidazole: ligand-induced structural response through alpha-helical repositioningSean C Gay, Ling Sun, Keiko Maekawa, et al.
Molecular Pharmacology|August 31, 2011
Structures of cytochrome P450 2B6 bound to 4-benzylpyridine and 4-(4-nitrobenzyl)pyridine: insight into inhibitor binding and rearrangement of active site side chainsManish B Shah, Jaime Pascual, Qinghai Zhang, et al.
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|December 18, 2007
An unexpected outcome of surface engineering an integral membrane protein: improved crystallization of cytochrome ba(3) from Thermus thermophilusBin Liu, V Mitch Luna, Ying Chen, et al.
The Journal of Biological Chemistry|February 7, 2012
Crystal structure of human cytochrome P450 2D6 with prinomastat boundAn Wang, Uzen Savas, Mei-Hui Hsu, et al.
Archives of Biochemistry and Biophysics|January 9, 2013
X-ray crystal structure of the cytochrome P450 2B4 active site mutant F297A in complex with clopidogrel: insights into compensatory rearrangements of the binding pocketManish B Shah, Hyun-Hee Jang, Qinghai Zhang, et al.
Molecular Pharmacology|August 4, 2012
In silico and intuitive predictions of CYP46A1 inhibition by marketed drugs with subsequent enzyme crystallization in complex with fluvoxamineNatalia Mast, Marlin Linger, Matthew Clark, et al.
Pageof 10